SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

      Date of Report (Date of earliest event reported):  December 23, 2002

                              LIFECELL CORPORATION
               (Exact Name of Registrant as Specified in Charter)

         Delaware                     01-19890                  76-0172936
(State Or Other Jurisdiction        (Commission                (IRS Employer
Jurisdiction Of Incorporation)      File Number)             Identification No.)


               One Millenium Way
               Branchburg, New Jersey                              08876
      ---------------------------------------------------------------------
     (Address of Principal Executive Offices)                    (Zip Code)

      Registrant's telephone number, including area code   (908) 947-1100


                                      -1-

Item 5.   On December 23, 2002, LifeCell Corporation announced the appointment
          of  Lisa  Colleran  to  the  position  of  Vice President - Marketing
          and  Business  Development.


Item 7.   Financial  Statements  and  Exhibits.

          (c)   Exhibits

          99.1  Press release dated December 23, 2002.


                                      -2-

                                    SIGNATURE

     Pursuant  to  the  requirements of the Securities Exchange Act of 1934, the
Registrant  has  duly  caused  this  report  to  be  signed on its behalf by the
undersigned  hereunto  duly  authorized.


                                         LIFECELL CORPORATION

                                         By:  /s/  Steven T. Sobieski
                                            -------------------------
                                            Steven T. Sobieski
                                            Chief Financial Officer

Date:  December 27, 2002



                                      -3-